BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  C2C Services & Suppliers™
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile

 

Aduro Biotech 

626 Bancroft Way
Suite 3C
Berkeley  California  94710  U.S.A.
Phone: 510-848-4400 Fax: n/a


SEARCH JOBS




Industry
Biotechnology

Segment
Biotechnology





 Company News
Aduro Biotech Collaborates With Leaders In Cancer Research On Investigator-Sponsored Phase 2 Trial Combining Aduro’s Innovative Immunotherapies With Anti-PD-1 Technology To Treat Patients With Advanced Pancreatic Cancer 2/26/2015 10:55:26 AM
Aduro Biotech Appoints Sylvia R. Wheeler As Senior Vice President, Corporate Affairs And Investor Relations 2/11/2015 12:50:12 PM
Aduro Biotech Meets Development Milestone In Immuno-Oncology Collaboration With Janssen Biotech Inc. (JNJ) For Treatment Of Prostate Cancer 2/9/2015 8:45:45 AM
Aduro Biotech Reports Long-Term Survival And Immune Biomarker Data From Phase 2 Clinical Trial Of Its Immuno-Oncology Regimen In Patients With Pancreatic Cancer 1/20/2015 9:04:10 AM
Aduro Biotech Announces Phase 2 Clinical Trial Results For Pancreatic Cancer Combination Immunotherapy Published In Journal Of Clinical Oncology 1/13/2015 9:32:46 AM
Berkeley's Aduro Biotech Banks $51.4 Million 1/5/2015 6:19:58 AM
Aduro Biotech Announces Preclinical Data Presented At American Association for Cancer Research Tumor Immunology And Immunotherapy Conference 12/4/2014 9:07:33 AM
Aduro Biotech Presents Updated Interim Results From Phase 1b Clinical Trial In Mesothelioma At International Mesothelioma Interest Group Conference 10/24/2014 10:51:24 AM
Aduro Biotech Announces Interim Phase 1B Clinical Data Of CRS-207 For The Treatment Of Mesothelioma Accepted For Oral Presentation At The International Mesothelioma Interest Group Conference 10/16/2014 11:23:28 AM
Berkeley's Aduro Biotech Strikes $817 Million Lung Cancer Pact With Janssen Biotech Inc. (JNJ) 10/16/2014 6:50:36 AM
12345